Strains of Escherichia coli, Enterobacter aerogenes, and Enterobacter cloacae that were resistant to ceftazidime (MIC > 16 ,ug/ml) but susceptible to BMY 28142 (MIC < 4 ,ug/ml) were found to contain higher levels of j-lactamase activity (50-to 3,340-fold) than control strains of the corresponding species. Ceftazidime was at least as resistant as BMY 28142 to hydrolysis by these enzymes. However, the apparent K, of BMY 28142 for each enzyme was larger (8-to >20-fold) than that of ceftazidime; i.e., the affinity of these enzymes for BMY 28142 appeared to be lower than that for ceftazidime. Thus, BMY 28142 was affected less than ceftazidime by a mechanism of resistance that depends, at least in part, on the relative affinities of cephalosporins for the j3-lactamases of these species. These results indicate that the affinity between a jI-lactamase and a cephalosporin may be a distinguishing factor in the evaluation of ,-lactamase-resistant cephalosporins and suggest that affinity can play a major role in susceptibility to highly ,(-lactamase-resistant cephalosporins.
(MIC > 16 pug/ml) to ceftazidime but susceptible to BMY 28142 (MIC < 4 ,ug/ml). Resistance to cephalosporins that are intrinsically stable to P-lactamase hydrolysis has been correlated with high levels of ,B-lactamase activity (1, 2, (9) (10) (11) 14) . The concept of trapping or nonhydrolytic interference was proposed to explain this apparently paradoxical phenomenon (8, 10, 11, 14, 15) . Criticism of this concept, based on the premise that for this mechanism to operate the total number of P-lactamase molecules must exceed the number of P-lactam molecules (9), does not take into consideration the presence of the outer membrane barrier, as discussed by Vu and Nikaido (13) . Their analysis, based on outer membrane permeability, kinetic parameters of the enzyme, affinity toward penicillin-binding proteins, and MIC, suggests that hydrolysis may be more important than nonhydrolytic binding for ,-lactams such as cefoperazone, cefoxitin, and cefotaxime (13) . However, the results of their calculations for ceftazidime, which is much more resistant to hydrolysis than the other three cephalosporins, were less conclusive with respect to hydrolysis versus nonhydrolytic interference as the major determinant of resistance in the single E. cloacae strain that they examined.
We therefore investigated the contribution of P-lactamaserelated factors to the difference in the relative activity of ceftazidime and BMY 28142 against some of these ceftazidime-resistant isolates. For each species one to three strains resistant to ceftazidime but susceptible to BMY 28142 were compared with a control strain for which MICs of BMY 28142 and ceftazidime were similar to the respective MIC50s * Corresponding author. (MICs for 50% of the strains) of the two cephalosporins for the species (5).
MATERIALS AND METHODS
Bacterial strains. The bacterial strains used in this study are listed in Table 1 . All strains whose designations start with "A" were clinical isolates; they were received from the following individuals: G. Bodey (A25049, received as a ceftazidime-resistant strain, no. 289), T. Gavan (A21160, received as culture G1320), E. Konopka (A20942), M. J. Madden (A15154), and L. Sabath Determination of MIC. MICs were determined on MuellerHinton medium by the serial twofold dilution technique as previously described (5).
Bacterial growth, P-lactamase release, and quantitation.
Cells from cultures grown in brain heart infusion broth (BBL Microbiology Systems) to the late exponential phase were harvested by centrifugation (16,300 x g, 10 min, 4°C), suspended in 50 mM KH2PO4 (pH 7.0), sedimented again (31,000 x g, 10 min, 4°C), resuspended in 100 mM acetic acid-4 mM EDTA (pH 5.0) (0.33 g [wet wt] ml-1), and frozen, using a dry ice-acetone bath. After thawing and two additional cycles of freezing and thawing, cells and debris were removed by centrifugation (31,000 x g, 15 min, 4°C). Proteases in the supernatant were inhibited with phenylmethylsulfonyl fluoride and pepstatin A added to concentrations of 0.5 mM and 2 ,uM, respectively. The freeze-thaw procedure yielded ,-lactamase activity equivalent to that released by sonic disruption of the cells (unpublished data) but with a 20-fold-higher specific activity. Residual cellassociated activity was not detected in those strains that have been tested. The relative activity in the freeze-thaw supernatant was determined by spectrophotometric assay (Hewlett-Packard 8450A spectrophotometer), using nitrocefin (6) as the substrate at 0.1 mM in 50 mM KH2PO4 (pH 7.0) at 25°C. Activity per cell was calculated by dividing the total activity in the crude supernatant preparation by the viable cell count determined at the time of harvesting.
Thin-layer isoelectric focusing. The freeze-thaw supernatant from each bacterial strain was analyzed by thin-layer isoelectric focusing on LKB Ampholine polyacrylamide plates, pH 3.5 to 9.5, at 4°C, using the LKB 2117 Multiphor and LKB 2103 power supply. After pre-equilibration for 15 min at 30 W, 1,800 V, and 50 mA, samples were loaded and run for 2 h in the constant-power mode at the same settings. Assay of B-lactamase activity. P-Lactamase activity was measured spectrophotometrically in 50 mM KH2PO4 at pH 7.0. Relative rates of hydrolysis were determined at an initial substrate concentration of 0.1 mM. The wavelengths and molar extinction coefficients were as follows: BMY 28142, AE at 260 nm = 8,200; cephaloridine, AE at 270 nm = 8,340; and nitrocefin, AE at 510 nm = 19,000. All assays were run at 25°C. Km values for nitrocefin were calculated from Lineweaver-Burk plots. Apparent K,s were calculated by the method of Dixon (6) from the rates of hydrolysis of nitrocefin in the presence of various concentrations of BMY 28142 and ceftazidime. Nitrocefin and "inhibitor" were added simultaneously to yield values reflecting initial binding interactions.
High-pressure liquid chromatography. High-pressure liquid chromatography analysis was done on a Waters C18 ,u-Bondapak reversed-phase column, using isocratic elution with 10% methanol in 50 mM KH2PO4, pH 7.0. An Hitachi 100-40 spectrophotometer (280-nm wavelength) was the detection instrument.
RESULTS AND DISCUSSION
The MIC of BMY 28142 was eightfold lower than that of ceftazidime for the ceftazidime-susceptible strains ( Table 1 , first strain of each species); for ceftazidime-resistant strains, the MIC differential was 32-to 125-fold or greater.
Each of these strains contained a single P-lactamase as determined by thin-layer isoelectric focusing of crude supernatant preparations. Based on their reactivity profiles (data not shown) and pl (Table 1) , all were class I cephalosporinases (7). The pIs of the enzymes from the E. cloacae strains varied between 8.2 and 9.0, but the three E. aerogenes enzymes all had a pl of 8.5 and the two Escherichia coli enzymes had a pl of 9.2.
Within each species, purified enzymes had similar Km values for nitrocefin. The variations could be within experimental limits or reflect minor differences in enzymes. When enzymatic degradation of 0.1 mM BMY 28142 or ceftazidime was detectable, their rates of hydrolysis were comparable and <0.25% of the rate of hydrolysis of cephaloridine (Table  1) . Only with the P-99 enzyme could any significant difference in the rates of hydrolysis of BMY 28142 and ceftazidime be shown. For this one enzyme the rate of hydrolysis of ceftazidime was eightfold slower than that of BMY 28142.
According to Vu and Nikaido (13) , hydrolysis rates at substrate concentrations of 0.1 to A major, consistent difference between the ceftazidimeresistant and ceftazidime-susceptible strains was the large differential in 1-lactamase activity per cell. ,B-Lactamase activities were 50-to 3,340-fold higher in the crude supernatant preparations from ceftazidime-resistant strains than in those from ceftazidime-susceptible strains (Table 1) . However, since ceftazidime was at least as stable as BMY 28142 to the degradative action of these enzymes, the greater MIC differential for the ceftazidime-resistant strains did not appear to be related to amplification of small differences in the rates of hydrolysis of the two cephalosporins.
The affinity of BMY 28142 for these P-lactamases, as estimated from the apparent inhibition constants (3) for nitrocefin hydrolysis, appeared to be much lower than that of ceftazidime. The apparent Kis for ceftazidime (8 to 115 ttM) were at least 8-fold, and in most instances 20-fold, lower than those for BMY 28142 (.1 mM for five and 180 to 460
,uM for three of the eight enzymes tested). Although the ceftazidime-resistant and ceftazidime-susceptible strains are unrelated and possibly produce minor variants of similar enzymes within each species, the consistent correlation of a larger MIC differential between ceftazidime and BMY 28142 with production of higher amounts of P-lactamases, all having lower affinities for BMY 28142 than ceftazidime in six strains of three species, as compared with randomly selected control strains, is in itself remarkable. These data are consistent with the concept of a nonhydrolytic barrier mechanism of resistance (4, 8, 10, 12, 13) . The lower affinity of BMY 28142 may result in less interaction with P-lactamases and thus less limitation of access to the target binding proteins. A similar correlation of lower MIC with lower affinity for ,-lactamases has been reported for cefpirome (HR 810) in comparison to cefotaxime for E. cloacae (11) . Cefpirome had both a lower MIC for several strains of E. cloacae and lower affinity for the P-lactamases from these strains despite being slightly less stable than cefotaxime to enzymatic hydrolysis (11) .
Alternately, hydrolysis could provide the dominant contribution if the rate of hydrolysis/rate of penetration quotient (at equilibrium) was significantly greater for ceftazidime than for BMY 28142. In view of the difficulties in directly measuring rates of penetration of unlabeled, slowly hydrolyzed compounds into intact, growing cells and accurately assessing the kinetic characteristics of ,-lactamases in situ, i.e., within the periplasm, this is currently a moot point with respect to compounds such as ceftazidime and BMY 28142. However, the elegant studies of Nikaido and co-workers (e.g., reference 13) have demonstrated the likely predominance of hydrolysis in resistance to certain other ,-lactams. Application of those techniques may lend support to the hydrolytic alternative.
Whether the permeability of the outer membrane and the array of ,B-lactam-binding proteins is the same in the overproducers as in the control strains, and thus whether only the high levels of ,B-lactamase are integral to the resistance of these strains, remains to be determined. Restricted permeability is necessary (13) regardless of whether hydrolysis or nonhydrolytic interferences has the greater influence on the difference in susceptibility to ceftazidime and BMY 28142. Higher permeability restriction per se was probably not a major factor, since the MICs of ceftazidime and BMY 28142 both were two-to fourfold higher for ompB mutants than for parental strains of Escherichia coli (kindly provided by R. Hancock); thus, the ratios of the MICs were unchanged, quite unlike the observations described above. More detailed studies with the ceftazidime-resistant strains will be required to address this question directly.
Regardless of mechanism, these results show that the activity of BMY 28142 against strains which produce high levels of 1-lactamase is not reduced to the same extent as the activity of ceftazidime or cefotaxime (9) . Hence, compounds that have a low affinity for chromosomally encoded ,Blactamases, in addition to high resistance to enzymatic hydrolysis, may represent an important therapeutic advance beyond currently available P-lactam antibiotics.
